Urinary Infection Recurrence and Its Related Factors in Urinary Tract Infection

AUTHORS

Simin Sadeghi Bojd 1 , Gholamreza Soleimani 1 , Alireza Teimouri 1 , * , Negar Aflakian 2

1 Children and Adolescents Health Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran

2 Medical School, Zahedan University of Medical Sciences, Zahedan, Iran

How to Cite: Sadeghi Bojd S, Soleimani G, Teimouri A, Aflakian N. Urinary Infection Recurrence and Its Related Factors in Urinary Tract Infection, Int J Infect. 2018 ; 5(2):e64903. doi: 10.5812/iji.64903.

ARTICLE INFORMATION

International Journal of Infection: 5 (2); e64903
Published Online: April 24, 2018
Article Type: Research Article
Received: January 24, 2018
Revised: March 28, 2018
Accepted: April 9, 2018
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Recurrent urinary tract infection (UTI) is one of the major health problems in children because of its high rate of occurrence. This study aimed at evaluating the frequency of recurrent urinary tract infection and related factors in children aged two months to 15 years old, refereed to the pediatric nephrology clinic of Zahedan city.

Methods: In this descriptive study, 270 children with urinary tract infection were studied. The sampling method was convenient. Information was gathered from patients and their files. Data was analyzed by the SPSS version 18 software, using Chi Square and T-test.

Results: The mean age of the children was 4.3 ± 3.7 years old. Thirty-four children (12.6%) were male and 236 (87.4%) female (P > 0.05). Overall, 109 children (73.6%) with recurrent UTI and 53 children (44.2%) without recurrent UTI had abnormal ultrasonography (P = 0.001). Furthermore, 115 children (76.7%) with recurrent UTI and 100 children (83.3%) with first UTI had positive results for E. coli culture (P = 0.177). Seventy-nine children (54.5%) with recurrent UTI and 61 children (39%) with first UTI were diagnosed to have elimination syndrome (P = 0.067). Abnormal VCUG was found in 39 children (47.6%) of 82 children with recurrent UTI yet children with first UTI had normal VCUG (P = 0.001).

Conclusions: There was no difference regarding age, gender, dysfunctional elimination syndrome, and urine culture in children with recurrent UTI compared to those with first UTI, yet abnormal VCUG, kidney, and urinary tract ultrasonography were much more common in children with recurrent UTI.

Keywords

Urinary Tract Infection Recurrent Children

Copyright © 2018, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited

1. Background

The most prevalent disease of the urinary system is Urinary Tract Infection (UTI), specially in children, with a prevalence of 9% in more than 38 C febrile infants below 60 days old (1, 2). Urinary Tract Infection is diagnosed when 105 colonies are cultured in urine sampling with the clean catch method, more than 104 in catheter sampling, and any colony count from suprapubic urine sampling (2-5). Escherichia coli is the most common infecting organism in uncomplicated UTI. It causes about 85% of community-acquired infections and approximately 50% of nosocomial infections. Other gram-negative microorganisms causing UTI include Proteus, Klebsiella, Citrobacter, Enterobacter, and Pseudomonas spp. Gram-positive pathogens, such as Enterococcus faecalis, Staphylococcuss aprophyticus, and group B streptococci, can also infect the urinary tract. Anaerobic microorganisms are frequently encountered in suppurative infections of the genitourinary tract (6-10). Different types of UTIs are cystitis, pyelonephritis, and renal abscess in the kidney or its surrounding. Urinary tract system and urine itself should be sterile, naturally. At least one episode of UTI is experienced in children by the age of 11 years old and this happens in 8% and 10% of females and males, respectively, and during life time is 30% in females and about 1% in males. About 75% of infants below three months old with bacteriuria are male; this value reaches 10% between three to eight months, and after 12 months of age it is seen in girls only (11). Urinary Tract Infection in children does not have clear signs and symptoms compared to adults and it changes with growing up due to the unusual symptoms presentation like losing weight, Failure to Thrive (FTT), anorexia, icterus or fever of unknown origin (12, 13), yet in infants it is usually presented with FTT, nutritional disorders, diarrhea, fever of unknown origin and increased bilirubin gastrointestinal symptoms like colic, irritability, and agitation (7-12). Children of two to six years of age may have gastrointestinal symptoms as well; however, classic signs and symptoms of UTI, including urgency, dysuria, frequency, and lower abdominal pain, also appear.

Urinary Tract Infection accrues in males more than females in the first month of life (13-15) and is more common in females from the second month to adulthood. Furthermore, UTI relapse is two or more episodes of infection in a six-month period (16). Recurrence occurs with two types of relapse and reinfection. Infection repetition with the previous infection pathogen is called relapse. However, reinfection is considered when infection reoccurs with another pathogen different from the previous infection episode. Relapse usually occurs two weeks after the end of treatment and reinfection occurs months after the first episode of infection (17). Children below six years of age have are at greater risk of reinfection (6% to 18%). The risk of reinfection within a year in a patient with one episode of infection is nearly 25% and it reaches 50% in those with two previous episodes of infection and 80% in children with three previous episodes. Diagnosis is based on history taking and physical examination. Early complications of UTI are septicemia or bacteremia and delayed, such as hypertension, chronic renal failure, and reflux nephropathy. Therefore, prompt diagnosis and treatment is of great importance. Scar is the most common kidney parenchymal disease due to pyelonephritis and is one of the most important causes of hypertension in children and young adults (16, 18-21). Prevention from repetitive infection and its complication is the most important goal of treatment, yet achieving this target needs a close consideration of different factors, such as age, gender, and underlying diseases. Behavioral disorders, such as delaying urination or defecation, should be assessed in children with UTI to prevent further episodes of infection. On the other hand, urinary tract anomalies, such as vesicoureteral reflux (VUR) are considered as an important predisposing factor for UTI, which increase the risk of infection up to 37% (19, 22, 23). The importance of performing such study is apparent considering the high prevalence and important complications of UTI. Therefore, the present study aimed at assessing UTI prevalence and its underlying factors in children aged two months to 15 years admitted to pediatric clinics of Zahedan City, Iran.

2. Methods

This study was a retrospective analytic cross-sectional study with the aim of assessing UTI prevalence and its underlying factors in children. The patients were selected for the study from 2016 for one and a half years. They were followed for at least 6 months for responding to treatment. Medical records of all patients aged two months to 15 years were assessed and from them, those with two or more episodes of UTI in the last six-month were selected. The sampling was hospital-based. The sampling was performed amongst those, who referred to pediatric clinics of Zahedan City, Iran.

Exclusion criteria were one episode of infection and lack of attendance to follow-up to assess reinfection. Using sample size formula for cross sectional study “N = (Zα / E ) 2 P(1-P)” with considering Zα = 1.96, α = 0.05, E = Marginal error = 0.25, and the interest proportion of P = 0.69, 270 samples were required for the study. Convenient sampling was used until the sample size was achieved. Several variables were recorded in designed forms, including age, gender, recurrent UTI, urinary tract anomaly, cultured bacteria, and elimination syndromes. After obtaining an approval from the ethics committee, patients’ documents were assessed and required information was recorded in special forms. In case of any reported anomaly, it was verified using ultrasonography. All data were recorded in special forms regarding the above-mentioned variables and bacteria grown on culture. Data was analyzed using SPSS 18 (SPSS Inc., IMB Corporation, Chicago, Illinois, USA) with application of Chi-square and Fisher’s exact tests. The significance level was considered at P ≤ 0.05.

3. Results

In this study, 270 children with UTI were assessed. The mean age of the patients was 4.3 ± 3.7 years. Thirty-four (12.6%) were male. Patients were assigned in two groups of recurrent and non-recurrent infection. There was no meaningful difference regarding age and gender between the two groups (P ≥ 0.05). From 150 children with recurrent UTI, 29 (19.3%) were aged below one year, 69 (46%) were aged one to five years, and 52 (34.7%) were aged over five years. In this study, 109 (73.6%) children with recurrent UTI and 53 (44.2%) children with first UTI had urogenital anomaly; the difference was statistically significant (P = 0.001). Escherichia coli was detected in 115 (76.7%) children with recurrent UTI and 100 (83.3%) children with non-recurrent infection; the difference was not statistically significant (P = 0.177). In children with recurrent UTI, 38 (26.2%) had urine incontinency, 27 (18.6%) defecation incontinency, and 14 (9.7%) both urine and feces incontinency. In children with first UTI, 24 (20.3%) had urine incontinency, 12 (10.2%) defecation incontinency, and 10 (8.5%) both urine and feces incontinency; the difference was not statistically significant (P = 0.067). In this investigation, 82 children with recurrent UTI underwent voiding cystourethrography, which had abnormal results in 39 (47.6%). In those with non-recurrent UTI, 23 underwent VCUG and none of them had abnormal results; the difference was statistically meaningful (P = 0.001).

Table 1. Comparison of Recurrence of Urinary Tract Infection in Children by Age and Gender
VariablesRecurrent InfectionNon-Recurrent InfectionP Value
Age, mean ± SD3.8 ± 4.53.6 ± 4.10.366
Gender, frequency (%)0.682
Males20 (13.3)14 (11.7)
Females130 (86.7)106 (88.3)
Total150 (55.6)120(44.4)
Table 2. Frequency of Recurrence of Urinary Tract Infection in Children by Age and Gender
VariablesNo.%
Age, y
Less than 12919.3
Between 1 - 56946
More than 55234.7
Total150100
Gender
Females13086.7
Males2013.3
Total150100
Table 3. Recurrent and Non-Recurrent Infection of Patients in Different Variable Groupsa
VariablesRecurrent InfectionNon-Recurrent InfectionTotalP Value
Urinary tract abnormalities0.001
Yes109 (6.73)53 (2.44)162 (4.60)
No39 (4.26)67 (8.55)106 (6.39)
Total148 (2.55)120 (8.44)268 (100)
Bacteria’s type0.177
E. coli115 (7.76)100 (3.83)215 (6.79)
Non E. coli35 (3.23)20 (7.16)55 (4.20)
Total150 (6.55)120 (4.44)270 (100)
Defective syndrome0.067
Urinary incontinence38 (2.26)24 (3.20)62 (6.23)
Fecal incontinence27 (6.18)12 (2.10)39 (8.14)
Urinary incontinence and stool14 (7.9)10 (5.8)24 (1.9)
Normal66 (5.45)72 (61)138 (5.52)
Total145 (1.55)118 (9.44)263 (100)
Voiding cystourethrography< 0.001
Normal43 (4.52)23 (100)66 (9.62)
Abnormal39 (6.47)0 (0)39 (6.47)
Total82 (1.78)23 (9.21)105 (100)

aValues are expressed as No. (%).

4. Discussion

This study showed no meaningful difference regarding age and gender between the two groups of recurrent and no recurrent UTI. Abnormal results of VCUG and ultra-sonography were significantly more in children with recurrent UTI. However, E. coli and dysfunctional elimination syndromes had no meaningful difference between the two groups.

Jantunen et al. (24) showed that UTI occurred in most neonates due to reversion. In another study by Snodgrass et al. (20), the prevalence and risk factors of renal scar were assessed in patients with febrile UTI compared to healthy children; from the study it was found that 4% had congenital renal dysplasia and 15.5% had focal defect.

The factors associated with more risks of scar formation were reflux, especially grades 4 and 5, recurrent UTI with fever and older age. Urine analysis and culture easily detects UTI and unwanted complication can be avoided by prompt diagnosis and appropriate management. Recurrent UTI should be treated more aggressively than a simple episode of infection (21, 25-27).

Vachvanichsanong et al. (15) conducted a follow up study for one year to evaluate the prevalence and to determine the risk factors of recurrent UTI in children. In their study, which included all UTI children aged less than 15 years old, over a ten-year period at hospitals, they found that recurrent UTI in normal children was low; while in children with a genitourinary (GU) anomaly or other underlying disease indicating an immune compromised host, the recurrence rates were significantly higher. The major significant risk factor of recurrent UTI was genitourinary anomaly (GA) and children with GA or VUR had recurrence rates of 43% or 37%, respectively. The results of Vachvanichsanong et al.’s study were in the same line as the current results in relation to the risk factors of recurrent UTI. Although different results concerning recurrence have been found in different studies, such differences can largely be explained by different methodologies, ages of children, and durations of follow-up. Panaretto et al. (28) reported a recurrence rate of 10% for UTI in normal preschool children and 30% in children with VUR. In accordance with the present study results, Panaretto et al. (28) reported that urinary tract abnormality, such as VUR, were more common in patients with recurrent UTI.

Mingin et al. (29) reported that 32.1% of children with febrile UTI developed its recurrence. Pennesi et al. (30) found that only 4.4% of children with UTI aged less than three years had recurrent UTI after their first UTI. The results of Mingin et al. (29) and Pennesi et al. (30) were comparable with the current study in age group of < 3 years and febrile status was the main cause of recurrent UTI. Therefore, the results of the present study varied because of the goals and methodology.

Nuutinen and Uhari (31) reported that infants with VUR in grades I and II were similar in UTI recurrence rate with normal children, and infants with grades III to V VUR had recurrent UTI more frequently than infants with low-grade VUR. However, in contrast, Smellie et al., (32) reported that the rates of recurrent UTI were the same between high- and low-grade VUR.

In these two studies, VUR grading was considered as a risk factor of recurrent UTI with dissimilar results. In the current study, VUR without regarding its grade, was considered and revealed as a risk factor of recurrent UTI. Dias et al. (33) in their study reported that recurrent UTIs occurred in 16.2% of patients. After adjustment UTI as clinical presentation, age < 6 months, female gender, dysfunctional elimination syndrome, and severe grade of reflux it was demonstrated as an independent predictor of recurrent UTI.

More recent studies concluded the prediction model of recurrent UTI and allowed for early recognition of patients at risk for long-term morbidity.

Bakker et al. (34) analyzed different risk factors with the factors in the present study for recurrent UTI. They focused on the influence of potty-training and found a strong correlation between daytime and/or night-time wetting, voiding frequency of more than 10 times a day, and nocturia and recurrent UTI. Similar reports with that of Bakker et al. indicated that fecal soiling was more frequent in recurrent UTI. Bakker et al. also found a significant correlations between recurrent UTI and single UTI.

Conway et al. (35) conducted a study to identify recurrent UTI risk factors in a pediatric sample and to determine the association of antimicrobial prophylaxis with recurrent UTI. Among a curded group of children, < 1% had a first UTI and race, age, and grade 4 to 5 vesicoureteral reflux were associated with increased risk of recurrent UTI, and the factors of gender and grade one to three vesicoureteral reflux were not associated with risk of recurrence. They also concluded that antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI, yet was associated with increased risk of resistant infections. Similar to Nuutinen and Uhari (31) and Smellie’s (32) studies, Conway et al. (35) considered the grade of vesicoureteral reflux and reported similar results.

Sutton et al. (36) investigated recent literatures on first febrile UTI addressed to a broad range of areas regarding the care of hospitalized patients. Overall, studies supported deep attention to the potential risks, expenses, and invasiveness of various approaches for evaluation. Proposed updates to practice included utilization of urinalysis for screening and diagnosis, transitioning to oral antimicrobials based on clinical improvement, and limiting the routine use of voiding cystourethrogram and antimicrobial prophylaxis. Swerkersson et al. (37) observed similarity between groups of patients regarding gender or age and progression, regression, and unchanged status. In progression, amongst children with vesicoureteral reflux (VUR) grade III to V, 65% had recurrent UTI. Both VUR grade III to V and recurrent UTI were associated with progression. In the regression group, high percentage had no VUR or grade I to II, and 10% had recurrent UTI. They concluded that young children with febrile UTI do not develop renal damage and if they do, the majority remain unchanged or regress over time. However, up to one-fifth of children with renal damage diagnosed after UTI are at risk of renal deterioration. These children are characterized by the presence of VUR grades III to V and recurrent febrile UTI and may benefit from follow-up.

4.1. Study Limitation

The limitation of this study was the lack of antimicrobial prophylaxis consideration. A randomized trial involving children in the community setting after first UTI comparing daily prophylaxis versus close follow-up would significantly improve understanding of the efficacy of antimicrobial prophylaxis.

4.2. Conclusion

From the study, it was concluded that recurrence was a serious problem in UTI. Furthermore, it was demonstrated that age, gender, dysfunctional elimination syndromes, and urine culture were similar in patients with and without recurrent urinary infection; however, VCUG and ultrasonography abnormal results were more prevalent in patients with recurrent UTI. It is suggested to perform further investigations to assess urinary infection recurrence and administer antibiotics in patients at risk of recurrent episodes of UTI. The long-term health of UTI children needs to be monitored in both normal children and children, who have a GU anomaly, even when antibiotic prophylaxis has been prescribed for indicated cases.

Acknowledgements

Footnote

References

  • 1.

    Zorc JJ, Levine DA, Platt SL, Dayan PS, Macias CG, Krief W, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics. 2005;116(3):644-8. doi: 10.1542/peds.2004-1825. [PubMed: 16140703].

  • 2.

    White B. Diagnosis and treatment of urinary tract infections in children. Am Fam Physician. 2011;83(4):409-15. [PubMed: 21322515].

  • 3.

    UTI Guideline Team , Cincinnati Children's Hospital Medical Center . Evidence-based care guideline for medical management of first urinary tract infection in children 12 years of age or less. 2010, [cited October 18]. Available from: http://www.cincinnatichildrens.org/svc/alpha/h/health-policy/uti.htm.

  • 4.

    Rushton HG. Urinary tract infections in children. Epidemiology, evaluation, and management. Pediatr Clin North Am. 1997;44(5):1133-69. doi: 10.1016/S0031-3955(05)70551-4. [PubMed: 9326956].

  • 5.

    Wu CT, Lee HY, Chen CL, Tuan PL, Chiu CH. High prevalence and antimicrobial resistance of urinary tract infection isolates in febrile young children without localizing signs in Taiwan. J Microbiol Immunol Infect. 2016;49(2):243-8. doi: 10.1016/j.jmii.2015.05.016. [PubMed: 26299351].

  • 6.

    Hanna-Wakim RH, Ghanem ST, El Helou MW, Khafaja SA, Shaker RA, Hassan SA, et al. Epidemiology and characteristics of urinary tract infections in children and adolescents. Front Cell Infect Microbiol. 2015;5:45. doi: 10.3389/fcimb.2015.00045. [PubMed: 26075187]. [PubMed Central: PMC4443253].

  • 7.

    Arshad M, Seed PC. Urinary tract infections in the infant. Clin Perinatol. 2015;42(1):17-28. vii. doi: 10.1016/j.clp.2014.10.003. [PubMed: 25677994]. [PubMed Central: PMC5511626].

  • 8.

    Kanellopoulos TA, Salakos C, Spiliopoulou I, Ellina A, Nikolakopoulou NM, Papanastasiou DA. First urinary tract infection in neonates, infants and young children: a comparative study. Pediatr Nephrol. 2006;21(8):1131-7. doi: 10.1007/s00467-006-0158-7. [PubMed: 16810514].

  • 9.

    Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008;27(4):302-8. doi: 10.1097/INF.0b013e31815e4122. [PubMed: 18316994].

  • 10.

    Stein R, Dogan HS, Hoebeke P, Kocvara R, Nijman RJ, Radmayr C, et al. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015;67(3):546-58. doi: 10.1016/j.eururo.2014.11.007. [PubMed: 25477258].

  • 11.

    Dai B, Liu Y, Jia J, Mei C. Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysis. Arch Dis Child. 2010;95(7):499-508. doi: 10.1136/adc.2009.173112. [PubMed: 20457696].

  • 12.

    Birnie K, Hay AD, Wootton M, Howe R, MacGowan A, Whiting P, et al. Comparison of microbiological diagnosis of urinary tract infection in young children by routine health service laboratories and a research laboratory: Diagnostic cohort study. PLoS One. 2017;12(2). e0171113. doi: 10.1371/journal.pone.0171113. [PubMed: 28199403]. [PubMed Central: PMC5310769].

  • 13.

    Robinson JL, Finlay JC, Lang ME, Bortolussi R, Canadian Paediatric Society ID, Immunization Committee CPC. Urinary tract infections in infants and children: Diagnosis and management. Paediatr Child Health. 2014;19(6):315-25. doi: 10.1093/pch/19.6.315. [PubMed: 25332662]. [PubMed Central: PMC4173959].

  • 14.

    Naveh Y, Friedman A. Urinary tract infection presenting with jaundice. Pediatrics. 1978;62(4):524-5. [PubMed: 362366].

  • 15.

    Vachvanichsanong P, Dissaneewate P, McNeil E. Childhood recurrent urinary tract infection in southern Thailand. Ren Fail. 2013;35(1):66-71. doi: 10.3109/0886022X.2012.741647. [PubMed: 23170976].

  • 16.

    Abolghasemi SH, Abadi A, Afjeei SA. Urinary tract infection, pediatric Emergency. Tehran: Nourdanesh and Babazadeh Pub; 2005.

  • 17.

    Ansari MS, Ayyildiz HS, Jayanthi VR. Is voiding cystourethrogram necessary in all cases of antenatal hydronephrosis? Indian J Urol. 2009;25(4):545-6. doi: 10.4103/0970-1591.57911. [PubMed: 19955688]. [PubMed Central: PMC2808667].

  • 18.

    Merrick MV, Notghi A, Chalmers N, Wilkinson AG, Uttley WS. Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 1: Reflux. Arch Dis Child. 1995;72(5):388-92. doi: 10.1136/adc.72.5.388. [PubMed: 7618902]. [PubMed Central: PMC1511097].

  • 19.

    Giorgi LJ, Bratslavsky G, Kogan BA. Febrile urinary tract infections in infants: renal ultrasound remains necessary. J Urol. 2005;173(2):568-70. doi: 10.1097/01.ju.0000149826.70405.c5. [PubMed: 15643258].

  • 20.

    Snodgrass WT, Shah A, Yang M, Kwon J, Villanueva C, Traylor J, et al. Prevalence and risk factors for renal scars in children with febrile UTI and/or VUR: a cross-sectional observational study of 565 consecutive patients. J Pediatr Urol. 2013;9(6 Pt A):856-63. doi: 10.1016/j.jpurol.2012.11.019. [PubMed: 23465483]. [PubMed Central: PMC3770743].

  • 21.

    Salo J, Ikaheimo R, Tapiainen T, Uhari M. Childhood urinary tract infections as a cause of chronic kidney disease. Pediatrics. 2011;128(5):840-7. doi: 10.1542/peds.2010-3520. [PubMed: 21987701].

  • 22.

    Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, et al. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring. Pediatrics. 2015;136(1):e13-21. doi: 10.1542/peds.2015-0409. [PubMed: 26055855]. [PubMed Central: PMC4485012].

  • 23.

    Becknell B, Schober M, Korbel L, Spencer JD. The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther. 2015;13(1):81-90. doi: 10.1586/14787210.2015.986097. [PubMed: 25421102]. [PubMed Central: PMC4652790].

  • 24.

    Jantunen ME, Saxen H, Salo E, Siitonen A. Recurrent urinary tract infections in infancy: relapses or reinfections? J Infect Dis. 2002;185(3):375-9. doi: 10.1086/338771. [PubMed: 11807720].

  • 25.

    Roupakias S, Sinopidis X, Karatza A, Varvarigou A. Predictive risk factors in childhood urinary tract infection, vesicoureteral reflux, and renal scarring management. Clin Pediatr (Phila). 2014;53(12):1119-33. doi: 10.1177/0009922813515744. [PubMed: 24366998].

  • 26.

    Williams GJ, Craig JC, Carapetis JR. Preventing urinary tract infections in early childhood. Adv Exp Med Biol. 2013;764:211-8. doi: 10.1007/978-1-4614-4726-9_18. [PubMed: 23654070].

  • 27.

    Singh SD, Madhup SK. Clinical profile and antibiotics sensitivity in childhood urinary tract infection at Dhulikhel Hospital. Kathmandu Univ Med J (KUMJ). 2013;11(44):319-24. [PubMed: 24899328].

  • 28.

    Panaretto K, Craig J, Knight J, Howman-Giles R, Sureshkumar P, Roy L. Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health. 1999;35(5):454-9. doi: 10.1046/j.1440-1754.1999.355417.x. [PubMed: 10571758].

  • 29.

    Mingin GC, Hinds A, Nguyen HT, Baskin LS. Children with a febrile urinary tract infection and a negative radiologic workup: factors predictive of recurrence. Urology. 2004;63(3):562-5. discussion 565. doi: 10.1016/j.urology.2003.10.055. [PubMed: 15028458].

  • 30.

    Pennesi M, L'Erario I, Travan L, Ventura A. Managing children under 36 months of age with febrile urinary tract infection: a new approach. Pediatr Nephrol. 2012;27(4):611-5. doi: 10.1007/s00467-011-2087-3. [PubMed: 22234625].

  • 31.

    Nuutinen M, Uhari M. Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol. 2001;16(1):69-72. doi: 10.1007/s004670000493. [PubMed: 11198607].

  • 32.

    Smellie JM, Prescod NP, Shaw PJ, Risdon RA, Bryant TN. Childhood reflux and urinary infection: a follow-up of 10-41 years in 226 adults. Pediatr Nephrol. 1998;12(9):727-36. doi: 10.1007/s004670050535. [PubMed: 9874316].

  • 33.

    Dias CS, Silva JM, Diniz JS, Lima EM, Marciano RC, Lana LG, et al. Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux. Pediatr Infect Dis J. 2010;29(2):139-44. doi: 10.1097/INF.0b013e3181b8e85f. [PubMed: 20135833].

  • 34.

    Bakker E, van Gool J, van Sprundel M, van der Auwera JC, Wyndaele JJ. Risk factors for recurrent urinary tract infection in 4,332 Belgian schoolchildren aged between 10 and 14 years. Eur J Pediatr. 2004;163(4-5):234-8. doi: 10.1007/s00431-003-1258-z. [PubMed: 14986116].

  • 35.

    Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA. 2007;298(2):179-86. doi: 10.1001/jama.298.2.179. [PubMed: 17622599].

  • 36.

    Sutton AG, Chandler N, Roberts KB. Recent Studies on the Care of First Febrile Urinary Tract Infection in Infants and Children for the Pediatric Hospitalist. Rev Recent Clin Trials. 2017;12(4):269-76. doi: 10.2174/1574887112666170816143639. [PubMed: 28814261].

  • 37.

    Swerkersson S, Jodal U, Sixt R, Stokland E, Hansson S. Urinary tract infection in small children: the evolution of renal damage over time. Pediatr Nephrol. 2017;32(10):1907-13. doi: 10.1007/s00467-017-3705-5. [PubMed: 28681079]. [PubMed Central: PMC5579136].

  • COMMENTS

    LEAVE A COMMENT HERE: